Metabomed Completes a $12.5 Million Raise in Order to Advance Its Lead Program Into Clinical Studies
Financing led by Yonjin Capital as well as current investors will allow the company to move its leading program to the clinic and strengthen its internal discovery pipeline
YAVNE, Israel and CAMBRIDGE, Massachusetts, Dec. 19, 2019 -- (Healthcare Sales &... Biopharmaceuticals, Oncology, Venture Capital Metabomed, cancer metabolism
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Israel Health | Middle East Health | Pharmaceuticals | Study | Venture Capital